ResearcherGerman Cancer Research CenterNo recent work listed

Johannes Betge

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9549-1866; OpenAlex author ID A5030055598. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective phase IV clinical trial. Co-author DOI 10.1016/j.jgo.2021.12.018 ↗
A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancreatic cancer patients (GrantPax). Co-author DOI 10.1186/s12885-018-4665-2 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Matthias P A Ebert · 2 shared papers, 2018–2022 · strength 0.20
- Paper Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective … DOI 10.1016/j.jgo.2021.12.018 ↗
- Paper A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancrea… DOI 10.1186/s12885-018-4665-2 ↗
Nicolai Härtel · 1 shared paper, 2022 · strength 0.13
- Paper Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective … DOI 10.1016/j.jgo.2021.12.018 ↗
Nicolai Haertel · 1 shared paper, 2018 · strength 0.08
- Paper A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancrea… DOI 10.1186/s12885-018-4665-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.